They're cashed up with about $3m on hand which is a big plus in the current economic environment - pretty tough times ahead for any business seeking a loan facility or capital raising.
Current outgoings are about $1m a year, and government R&D rebate also about $1m a year (if it continues), so that $3m should remain on hand for emergencies or a rainy day.
I don't think Covid 19 should greatly affect the progress of this business in the medium term, but it is and will certainly affect the share price.
CP1 Price at posting:
8.0¢ Sentiment: None Disclosure: Not Held